Market Research Industry Reports

MagForce AG (MF6) - Product Pipeline Analysis, 2018 Update

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

MagForce AG (MagForce) is a medical device company that offers nanotechnology-based therapy for cancer treatment. The companys products include NanoActivator, NanoTherm, NanoPlan and NanoTherm Therapy. Its NanoActivator creates a magnetic field that can be used to treat tumors in all areas of the body. MagForces NanoTherm is a liquid that reacts to the presence of magnetic field. The companys NanoPlan uses the bioheat transfer equation to help the physician in charge estimate treatment temperatures and the magnetic field strength. Its products are used in the treatment of prostate cancer, pancreatic cancer, esophageal cancer and glioblastoma. The company operates through therapy centers located in Berlin, Munster, Kiel, Cologne and Frankfurt, Germany. MagForce is headquartered in Berlin, Germany.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company MagForce AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



List of Tables 3
List of Figures 3
MagForce AG Company Overview 4
MagForce AG Company Snapshot 4
MagForce AG Pipeline Products and Ongoing Clinical Trials Overview 4
MagForce AG Pipeline Analysis Overview 6
MagForce AG - Key Facts 6
MagForce AG - Major Products and Services 7
MagForce AG Pipeline Products by Development Stage 8
MagForce AG Ongoing Clinical Trials by Trial Status 10
MagForce AG Pipeline Products Overview 11
NanoTherm - Brain Cancer 11
NanoTherm - Brain Cancer Product Overview 11
NanoTherm - Gastrointestinal Cancer 12
NanoTherm - Gastrointestinal Cancer Product Overview 12
NanoTherm - Pancreatic Carcinoma 13
NanoTherm - Pancreatic Carcinoma Product Overview 13
NanoTherm - Prostate Carcinoma 14
NanoTherm - Prostate Carcinoma Product Overview 14
NanoTherm - Prostate Carcinoma Clinical Trial 15
NanoTherm - Recurrent Glioblastoma 16
NanoTherm - Recurrent Glioblastoma Product Overview 16
Next-Generation Nanotherm 17
Next-Generation Nanotherm Product Overview 17
MagForce AG - Key Competitors 18
MagForce AG - Key Employees 19
MagForce AG - Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
MagForce AG, Recent Developments 21
Jul 02, 2018: MagForce Announces Enrollment of First Patient in its Pivotal, Three-Stage, Single-Arm Study of Focal Ablation of Prostate Cancer with NanoTherm Therapy 21
Jun 14, 2018: MagForce Co-Sponsors the University Hospital of Munsters Annual Brain Cancer Patient Event 21
Jun 12, 2018: MagForce Announces Collaboration Agreement for NanoTherm Therapy with Independent Public Clinical Hospital No. 4, Lublin, Poland 22
Jun 04, 2018: MagForce to host Lunch Symposium about Local Therapies for Malignant Gliomas at the 2018 meeting of the German Society of Neurosurgery (DGNC) 23
May 03, 2018: MagForce Publishes Financial Results for the Year 2017 and Operative Highlights 23
Feb 15, 2018: FDA expands treatment window for use of clot retrieval devices in certain stroke patients 25
Feb 10, 2018: MagForce USA Receives FDA Investigational Device Exemption Approval to Conduct A Clinical Trial With NanoTherm Therapy As Focal Ablation Treatment For Intermediate Risk Prostate Cancer 26
Nov 14, 2017: MagForce to participate at SNO 2017 Annual Meeting from November 16-19 in San Francisco, USA 27
Sep 29, 2017: MagForce Publishes Financial Results for the First Half of 2017 and Operative Highlights 28
Aug 10, 2017: MagForce announces positive results of 2017 Annual General Meeting 30
Appendix 31
Methodology 31
About GlobalData 34
Contact Us 34
Disclaimer 34

List Of Tables

List of Tables
MagForce AG Pipeline Products and Ongoing Clinical Trials Overview 4
MagForce AG Pipeline Products by Equipment Type 5
MagForce AG Pipeline Products by Indication 5
MagForce AG Ongoing Clinical Trials by Trial Status 5
MagForce AG, Key Facts 6
MagForce AG, Major Products and Services 7
MagForce AG Number of Pipeline Products by Development Stage 8
MagForce AG Pipeline Products Summary by Development Stage 9
MagForce AG Ongoing Clinical Trials by Trial Status 10
MagForce AG Ongoing Clinical Trials Summary 10
NanoTherm - Brain Cancer - Product Status 11
NanoTherm - Brain Cancer - Product Description 11
NanoTherm - Gastrointestinal Cancer - Product Status 12
NanoTherm - Gastrointestinal Cancer - Product Description 12
NanoTherm - Pancreatic Carcinoma - Product Status 13
NanoTherm - Pancreatic Carcinoma - Product Description 13
NanoTherm - Prostate Carcinoma - Product Status 14
NanoTherm - Prostate Carcinoma - Product Description 14
NanoTherm - Prostate Carcinoma - An Investigational Device Exemption, Phase III Study of NanoTherm therapy as Focal Ablation Treatment for Intermediate Risk Prostate Cancer 15
NanoTherm - Recurrent Glioblastoma - Product Status 16
NanoTherm - Recurrent Glioblastoma - Product Description 16
Next-Generation Nanotherm - Product Status 17
Next-Generation Nanotherm - Product Description 17
MagForce AG, Key Employees 19
MagForce AG, Other Locations 20
MagForce AG, Subsidiaries 20
Glossary 33

List Of Figures

List of Figures
MagForce AG Pipeline Products by Equipment Type 5
MagForce AG Pipeline Products by Development Stage 8
MagForce AG Ongoing Clinical Trials by Trial Status 10

MagForce AG (MF6) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

MagForce AG (MagForce) is a medical device company that offers na

USD 250View Report

MagForce AG (MF6) - Product Pipeline Analysis, 2018 Update

MagForce AG (MagForce) is a medical device company that offers nanotechnology-based therapy for cancer treatment. The companys products include NanoActivator, NanoTherm, NanoPlan and NanoTherm Therapy. Its NanoActivator creates a magnetic

USD 750View Report

MagForce AG (MF6) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

MagForce AG (MagForce) is a medical device company that offers na

USD 250View Report

MagForce AG Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

MagForce AG Company Profile is a detailed strategic and analytical report on MagForce AG. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF USD 750    USD 600
  • Site Licence USD 1500    USD 1200
  • Enterprise Wide Licence USD 2250    USD 1800
$ 600

Reports Details

Published Date : Jul 2018
No. of Pages :34
Country :Germany
Category :Medical Devices
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube